Skip to content
ChickenStockChickenStock
ResearchCRMD
Cormedix logo

Cormedix (CRMD) stock

NASDAQ

$4.68-2.90%(-0.14)

As of the Nov 17, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 17, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

5.94x

P/B

0.81x

P/S

0.91x

Find stocks with P/B ≤ 0.9×

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue decreased 47.1% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 12, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

5 SEC filings
  • Todisco JosephChief Executive Officer · Nov 13, 2026Open-market purchase80,000 shares · $391K
    Avg. price $4.89854,749 shares held after
  • Dillione JanetDirector · Sep 18, 2026Option exercise48,909 shares
    117,835 shares held after
  • Blum SusanChief Financial Officer · Aug 29, 2026Shares withheld for taxes8,424 shares · $70K
    Avg. price $8.3124,315 shares held after
  • Zelnick Kaufman BethChief Legal Officer · Aug 29, 2026Shares withheld for taxes8,424 shares · $70K
    Avg. price $8.3260,684 shares held after
  • Hurlburt ElizabethChief Operating Officer · Aug 29, 2026Shares withheld for taxes8,076 shares · $67K
    Avg. price $8.3270,463 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Cormedix (CRMD) stock information

NASDAQ

Cormedix (CRMD) is listed on NASDAQ. Its market capitalization is about $374M. On trailing-twelve-month earnings the P/E ratio is 5.94, and the P/B ratio is 0.81. Return on equity is 13.6%. These figures are computed in-house from official filings and are reference information only.

Cormedix — frequently asked questions

What is the P/E ratio of Cormedix (CRMD)?
On a trailing-twelve-month basis, CRMD trades at a P/E ratio of 5.94. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Cormedix?
CRMD has a market capitalization of about $374M. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.